Roche to Develop Assay as CDx for Ferring's Infertility Treatment | GenomeWeb

NEW YORK (GenomeWeb) – Roche will develop an existing assay as a companion diagnostic for Ferring Pharmaceuticals' potential infertility treatment under a deal announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.